Home › Calculator › IRIX Dividend Calculator 2026
IRIX Dividend DRIP Calculator 2026
237.56% YieldHealthcareIRIDEX Corporation · NASDAQ
Price: $0.84 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When IRIX pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your IRIX snowball 📈
$10,000 in IRIX → $66.20M in 10 years · $1,856,054.17/month
About IRIDEX Corporation (IRIX) — Dividend Analysis 2026
IRIDEX Corporation is a medical technology firm specializing in ophthalmology. They develop and supply advanced therapeutic laser systems, various delivery instruments, and essential consumable tools designed to address vision-threatening ocular conditions. Their product portfolio includes several laser consoles, each tailored for specific eye conditions. The Cyclo G6 system is specifically engineered for glaucoma treatment. For ailments like diabetic macular edema and other retinal pathologies, IRIDEX provides the IQ 532 and IQ 577 laser photocoagulation systems. Furthermore, the OcuLight series, encompassing models such as TX, SL, SLx, GL, and GLx, offers solutions for managing severe retinal issues like proliferative diabetic retinopathy, macular holes, and retinal tears or detachments. Beyond laser consoles, the company also manufactures specialized delivery instruments. These include the TxCell scanning laser delivery system, which empowers clinicians with multi-spot pattern scanning capabilities. A unique slit lamp adapter enables practitioners to integrate standard slit lamps into their diagnostic and therapeutic workflows. Additionally, a laser indirect ophthalmoscope is available for interventions targeting peripheral retinal disorders. IRIDEX's offerings extend to various probes. The MicroPulse P3 Probe, when coupled with the Cyclo G6 laser system, facilitates MicroPulse transscleral laser therapy. For managing uncontrolled glaucoma, the G-Probe is employed, while both the G-Probe and G-Probe Illuminate are utilized in procedures addressing refractory glaucoma. The EndoProbe product line supports a range of vitrectomy procedures. Their diverse client base spans ophthalmology professionals, academic and research hospitals, government healthcare facilities, specialized surgical centers, general hospitals, veterinary clinics, and private medical practices. Product distribution is handled via an internal and independent sales network across the United States, supplemented by independent distributors for its international markets. Originally incorporated in 1989 as IRIS Medical Instruments, Inc., the company adopted the name IRIDEX Corporation in November 1995. Its corporate headquarters are situated in Mountain View, California.
Compare IRIX with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full IRIX DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open IRIX position with:
🌍 IRIX Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold IRIX.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 237.56% | 234.76% | $23,756 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 201.93% | 199.13% | $20,193 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 190.05% | 187.25% | $19,005 / yr |
| 🇬🇧 UK ISA | 0% | 237.56% | 234.76% | $23,756 / yr |
| 🇬🇧 UK Taxable | 8.75% | 216.77% | 213.97% | $21,677 / yr |
| 🇨🇦 TFSA | 0% | 237.56% | 234.76% | $23,756 / yr |
| 🇨🇦 CA Taxable | 25% | 178.17% | 175.37% | $17,817 / yr |
| 🇦🇺 Super (pension) | 15% | 201.93% | 199.13% | $20,193 / yr |
| 🇦🇺 AU Taxable | 30% | 166.29% | 163.49% | $16,629 / yr |
| 🇩🇪 DE Taxable | 26.375% | 174.90% | 172.10% | $17,490 / yr |
| 🇫🇷 FR Taxable | 30% | 166.29% | 163.49% | $16,629 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 IRIX Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 IRIX Dividend Payment Schedule
IRIX pays quarterly — 4 times per year. Next ex-div: TBD.
📊 IRIX vs Healthcare Benchmarks
How IRIX compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for IRIX sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ IRIX Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Buy | 2026-08-24 | 5,368 | $0.75 | $4.0K | ||
| Buy | 2026-08-24 | 1,300 | $0.75 | $973.00 | ||
| A-Award | 2026-07-10 | 100,000 | — | — | ||
| A-Award | 2026-07-10 | 200,000 | $1.10 | $220.0K | ||
| A-Award | 2026-07-10 | 100,000 | — | — | ||
| A-Award | 2026-07-10 | 170,000 | $1.10 | $187.0K | ||
| A-Award | 2026-07-10 | 30,000 | — | — | ||
| J-Other | 2026-07-07 | 111,997 | — | — | ||
| F-InKind | 2026-06-13 | 2,691 | $1.12 | $3.0K | ||
| F-InKind | 2026-06-13 | 3,990 | $1.12 | $4.5K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where IRIX earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the IRIX dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
IRIDEX Corporation (IRIX) is currently trading at $0.84, 90% below its 52-week high. The current dividend yield is 237.56% based on an annual payout of $2.00 per share.
IRIX (IRIDEX Corporation) — 237.56% Dividend Yield Analysis
IRIDEX Corporation (IRIX) is a healthcare stock currently trading at $0.84 with a dividend yield of 237.56%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (237.56%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.